2-Propenoic acid,3-(5-nitro-1-?cyclohexen-1-yl)-,(1R)-4-?(diphenylamino)-1-methyl-4-oxo-2-?butyn-1-yl ester,(2E)-

2-Propenoic acid,3-(5-nitro-1-?cyclohexen-1-yl)-,(1R)-4-?(diphenylamino)-1-methyl-4-oxo-2-?butyn-1-yl ester,(2E)-

Intermediate for Vorapaxar. Vorapaxar (trade name: Zontivity) is a thrombin receptor (protease-activated receptor, PAR-1) antagonist. Vorapaxar is a new anti-platelet drug that and is used for persons with a history of myocardial infarction (heart attack) or persons with peripheral arterial disease. Vorapaxar has been approved by the U.S Food and Drug Administration on May 5, 2014.

Specifications

Product Name:                  2-Propenoic acid,3-(5-nitro-1-?cyclohexen-1-yl)-,(1R)-4-?(diphenylamino)-1-methyl-4-oxo-2-?butyn-1-yl ester,(2E)-

Synonyms:                         N/A

CAS Number:                     899809-60-0

Molecular Weight:            444.486

Molecular Formula:          C26H24N2O5

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               O=C(O[C@@H](C#CC(N(C3=CC=CC=C3)C2=CC=CC=C2)=O)C)/C=C/C1=CCCC([N+]([O-])=O)C1

  • $665.00
  • Ex Tax: $665.00

Available Options